Newsbenzinga
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
· Published
Article summary
FDA clears modular PMA pathway for Femasys' FemBloc, an investigational non-surgical permanent birth control device for women in the US.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…